T. Ferré
发表
F. Bosch,
A. Mas,
E. Riu,
2002,
Diabetes.
J. Ruberte,
F. Bosch,
C. Filloux,
2009,
Diabetologia.
F. Bosch,
E. Riu,
P. Otaegui,
2002,
Human gene therapy.
F. Bosch,
E. Riu,
P. Otaegui,
2003,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
F. Bosch,
A. Mas,
E. Riu,
2002,
The Biochemical journal.
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice
U. Smith,
J. Agudo,
J. Ruberte,
2008,
Diabetologia.
J. Agudo,
A. Casellas,
J. Ruberte,
2016,
Diabetes.
S. Tafuro,
J. Ruberte,
F. Bosch,
2012,
Diabetes.
F. Bosch,
S. Muñoz,
T. Ferré,
2006,
Diabetes.
J. Ruberte,
F. Bosch,
S. Muñoz,
2010,
Diabetologia.
V. Jiménez,
F. Bosch,
S. Muñoz,
2013,
Diabetes.
V. Jiménez,
A. Casellas,
F. Bosch,
2022,
Molecular therapy. Methods & clinical development.
Alex Mas,
F. Bosch,
A. Mas,
2003,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
J. Ruberte,
F. Bosch,
S. Muñoz,
2015,
Scientific Reports.
J. Agudo,
F. Bosch,
E. Riu,
2003,
Diabetologia.
J. Ayala,
T. Ferré,
E. King,
2012,
American journal of physiology. Endocrinology and metabolism.
F. Bosch,
E. Riu,
T. Ferré,
1996,
Proceedings of the National Academy of Sciences of the United States of America.
F. Mulero,
V. Jiménez,
A. Casellas,
2018,
EMBO molecular medicine.
C. Mann,
E. Ayuso,
V. Haurigot,
2013,
Diabetes.
A. Casellas,
F. Bosch,
T. Ferré,
2020,
Diabetes.
A. Casellas,
F. Bosch,
T. Ferré,
2014,
Molecular therapy. Methods & clinical development.
Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver
F. Bosch,
E. Riu,
T. Ferré,
1996,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
E. Ayuso,
V. Jiménez,
V. Haurigot,
2017,
Molecular therapy. Methods & clinical development.
F. Bosch,
E. Riu,
P. Otaegui,
2000,
Human gene therapy.